---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-102348"
form_type: "8-K"
ticker: "ISPC"
cik: "0001558569"
company_name: "iSpecimen Inc."
filed_at: "2022-09-22T23:59:59+00:00"
generated_at: "2026-06-23T08:00:33.763294+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# iSpecimen CEO Christopher Ianelli and COO Jill Mullan depart; CFO Tracy Curley named interim CEO

## Summary
- CEO and President Christopher Ianelli vacated positions on Sept 21, 2022, after non-renewal of employment agreement.
- COO Jill Mullan will vacate her role effective Oct 24, 2022, also due to non-renewal.
- CFO Tracy Curley appointed interim CEO effective Sept 21, 2022, while remaining CFO.
- Both departing executives will continue as employees through Oct 24, 2022, to ensure transition.
- Company is negotiating separation agreements; business and balance sheet described as strong.

## SEC filing metadata
- accession: 0001104659-22-102348
- form_type: 8-K
- ticker: ISPC
- cik: 0001558569
- company_name: iSpecimen Inc.
- filed_at: 2022-09-22T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1558569/000110465922102348/0001104659-22-102348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1558569/000110465922102348/tm2226424d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-102348
- JSON: https://secwatch.observer/filing/0001104659-22-102348.json
- Plain text: https://secwatch.observer/filing/0001104659-22-102348.txt

## Key facts
- Executive change
  Jill Mullan departed as Chief Operating Officer at iSpecimen Inc..
  - Action: vacate
  - Role: Chief Operating Officer
  source text: On September 20, 2022, the Board received a similar notice of departure from Jill Mullan to vacate the position of Chief Operating Officer of the Company, effective as of October 24, 2022, as a result of the non-renewal of her Executive Employment Agreement dated June 21, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465922102348/0001104659-22-102348-index.htm
- Executive change
  Christopher Ianelli departed as Chief Executive Officer and President at iSpecimen Inc..
  - Action: vacated
  - Role: Chief Executive Officer and President
  source text: On September 21, 2022, pursuant to the mutual agreement of Dr. Ianelli and the Board, Dr. Ianelli vacated his positions as Chief Executive Officer and President of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465922102348/0001104659-22-102348-index.htm
- Executive change
  Tracy Curley was appointed as Interim Chief Executive Officer at iSpecimen Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: The Board appointed Tracy Curley, who currently serves as the Chief Financial Officer and Treasurer of the Company, as Interim Chief Executive Officer of the Company, effective immediately upon Dr. Ianelli’s no longer serving as Chief Executive Officer and President of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465922102348/0001104659-22-102348-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.